All Stories

  1. The 2002 NIMH Provisional Diagnostic Criteria for Depression of Alzheimer’s Disease (PDC-dAD): Gauging their Validity over a Decade Later
  2. Differentiation chronic post traumatic stress disorder patients from healthy subjects using objective and subjective sleep-related parameters
  3. Pharmacological Therapy for Apathy in Alzheimer’s Disease: A Systematic Review and Meta-Analysis
  4. Tincture of opium for treating opioid dependence: a systematic review of safety and efficacy
  5. Diabetes Mellitus and Depression as Risk Factors for Dementia: SADEM Study
  6. Microbleeds and Alzheimer's neuropsychology: A Meta-analysis
  7. Neuropsychiatric symptoms in Alzheimer's disease (AD): How sensitive, how prevalent?
  8. OBSESSIVE COMPULSIVE SYMPTOMS BEFORE FRONTOTEMPORAL DEMENTIA: A REVIEW OF IMAGING CASE SERIES
  9. MEDICATIONS FOR DEPRESSION IN ALZHEIMER’S AND RISK OF MORTALITY: A LONGITUDINAL OBSERVATIONAL STUDY FROM THE ADTI
  10. Structural and functional neural adaptations in obstructive sleep apnea: An activation likelihood estimation meta-analysis
  11. Effect of RAAS blockers on adverse clinical outcomes in high CVD risk subjects with atrial fibrillation
  12. RE: Elucidating Pretreatment Cognitive Impairment in Breast Cancer Patients: The Impact of Cancer-Related Post-traumatic Stress
  13. The Association Between Obstructive Sleep Apnea and Alzheimer’s Disease: A Meta-Analysis Perspective
  14. Risk of progression to dementia from MCI, how significant is the impact of depression? A sensitivity report
  15. Prazosin for treating sleep disturbances in adults with posttraumatic stress disorder: a systematic review and meta-analysis of randomized controlled trials
  16. Effects of RAAS Blockers on Atrial Fibrillation Prophylaxis
  17. Personality and Psychological Aspects of Cosmetic Surgery
  18. The Prevalence of Depressive Symptoms in Frontotemporal Dementia: A Meta-Analysis
  19. Do antipsychotics prevent postoperative delirium? A systematic review and meta-analysis
  20. The Effect of S-Adenosylmethionine on Cognitive Performance in Mice: An Animal Model Meta-Analysis
  21. Clinical manifestations of Anti-NMDAR encephalitis: Case series and practical recommendations for treatment
  22. Pain Is Associated with Recurrent Falls in Community-Dwelling Older Adults: Evidence from a Systematic Review and Meta-Analysis
  23. Self-Rating Depression Scale (SDS)
  24. IPAT Depression Scale
  25. Pain and the Risk for Falls in Community-Dwelling Older Adults: Systematic Review and Meta-Analysis
  26. Prevalence of symptoms and risk of obstructive sleep apnea syndrome in the general population
  27. Music therapy, global affect and behavior in Alzheimer's disease: A meta-analytic perspective on outcomes and on music therapy methodologies
  28. Prevalence of depressive mood in frontotemporal dementia (FTD): A meta-analysis of studies from 2000 to present
  29. A quantitative systematic review of domain-specific cognitive impairment in lacunar stroke
  30. Effect of Selective Serotonin Reuptake Inhibitors in Alzheimer’s Disease with Comorbid Depression
  31. Memantine for depression symptoms in dementia: A feasibility meta-analytic examination of the evidence from trials for behavioral symptoms.
  32. Stay the course—is it justified?
  33. Prevalence of Mild Cognitive Impairment and Its Subtypes in the Mexican Population
  34. Abnormal ECG Patterns in Chronic Post-War PTSD Patients: A Pilot Study
  35. Smoking Tobacco and Collective Myopia
  36. Analysis of Mechanisms Underlying Depressive and Addictive Comorbid Disorders in Adolescents Should Not Ignore Nicotine Use and Dependence
  37. Toward a Meta-Analytic Approach of Sex Differences in Episodic Memory of Schizophrenia Patients: Exploratory Findings
  38. Should We Treat Auditory Hallucinations with Repetitive Transcranial Magnetic Stimulation? A Metaanalysis
  39. Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review
  40. Meta-Analysis of Depressive Symptoms in Dual-Diagnosis Schizophrenia
  41. Oral Cholinesterase Inhibitor Add-on Therapy for Cognitive Enhancement in Schizophrenia
  42. Selective Serotonin Reuptake Inhibitor (SSRI) Add-On Therapy for the Negative Symptoms of Schizophrenia
  43. Computerized assessment of cognition in schizophrenia: Promises and pitfalls of CANTAB
  44. Sur la première ligne : sondage pour un partage. Les omnipraticiens et la schizophrénie
  45. The impact of atypical antipsychotic medications on long-term memory dysfunction in schizophrenia spectrum disorder: a quantitative review
  46. Cognitive discernible factors between schizophrenia and schizoaffective disorder
  47. A meta-analysis of negative symptoms in dual diagnosis schizophrenia
  48. Atypical antipsychotic medications and memory enhancement in schizophrenia